文献速递前列腺增生与排尿功能障碍泌尿系感染

抗生素预防用药时长对A型肉毒毒素膀胱内注射后尿路感染发生率的影响

Impact of Duration of Antibiotic Prophylaxis on Incidence of UTI after OnabotulinumtoxinA Injection.
PubMed 文献 · Urology · 2022-05-17

该回顾性队列研究纳入2014至2020年接受诊室A型肉毒毒素(BTX)膀胱内注射的膀胱过度活动症患者290例、共896个注射周期,比较无抗生素、单日和多日(3-7天)预防方案后30天内尿路感染发生率。结果显示总体尿路感染发生率为11.4%,任何抗生素预防均与较低的尿路感染发生率相关(单日OR 0.34,多日OR 0.47),单日与多日方案间无差异(OR 1.38)。

要点

  • 任何抗生素预防较无抗生素与BTX注射后30天内尿路感染发生率更低相关(单日OR 0.34,多日OR 0.47)。
  • 单日与多日抗生素预防方案在预防BTX后尿路感染方面无差异(OR 1.38,95%CI 0.80-2.38,P=.249)。
  • 复发性尿路感染史(OR 3.77)和慢性耻骨上膀胱造瘘管(OR 2.88)是尿路感染的额外预测因素。

核心结论

  • 多日抗生素预防方案在预防BTX膀胱内注射后尿路感染方面并不优于单日方案。
  • 与无抗生素相比,任何抗生素预防均与显著更低的尿路感染发生率相关。

研究设计与样本

  • 回顾性队列研究,纳入2014至2020年接受诊室BTX注射的膀胱过度活动症患者。
  • 共纳入290例患者、896个BTX注射周期。
  • 比较无抗生素、单日和多日(3-7天)抗生素预防方案后30天内尿路感染发生率。

主要发现

  • 877个注射周期(97.7%)为女性,平均年龄61.4岁(范围20-96;标准差13.3)。
  • 无抗生素预防112个(12.5%),单日方案595个(66%),多日方案(3-7天)189个(21%)。
  • 30天内尿路感染总体发生率为11.4%。
  • 多因素logistic回归显示,任何抗生素预防与较低的尿路感染发生率相关(单日OR 0.34;95%CI 0.19-0.61;P<.001;多日OR 0.47;95%CI 0.24-0.92;P=.029)。
  • 复发性尿路感染史(OR 3.77;95%CI 2.23-6.39;P<.001)和慢性耻骨上膀胱造瘘管(OR 2.88;95%CI 1.04-7.95;P=.041)是额外预测因素。

关键数值与推荐

  • 单日与多日抗生素预防方案间无差异(OR 1.38;95%CI 0.80-2.38;P=.249)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the impact of duration of antibiotic prophylaxis on incidence of urinary tract infection (UTI) after intravesical OnabotulinumtoxinA (BTX) injection. METHODS: A retrospective cohort study of patients with overactive bladder who underwent office BTX injections from 2014 to 2020. UTI incidence within 30 days of BTX was compared between 3 durations of antibiotic prophylaxis: no antibiotic, single day, or multiple day course. Association of UTI with units of BTX, body mass index, history of diabetes, immunosuppression, neurogenic overactive bladder, chronic catheter, or recurrent UTI were investigated. RESULTS: Two hundred ninety patients and 896 cycles of BTX injections were included: 877 injections (97.7%) were women, with mean age 61.4 years (range 20-96; SD 13.3). No antibiotic prophylaxis was given to 112 (12.5%) patients, 595 (66%) received a single day, and 189 (21%) received a multiple day regimen (3-7 days). Overall incidence of UTI within 30 days was 11.4%. On multivariable logistic regression, use of any antibiotic prophylaxis was associated with a lower incidence of UTI (single odds ratio [OR] 0.34; 95% confidence interval [CI] 0.19-0.61; P < .001; multiple OR 0.47; 95% CI 0.24-0.92; P = .029), with no difference between single and multiple day regimens (OR 1.38; 95% CI 0.80-2.38; P = .249). History of recurrent UTI (OR 3.77; 95% CI 2.23-6.39; P < .001) and chronic suprapubic catheter (OR 2.88; 95% CI 1.04-7.95; P = .041) were additional predictors. CONCLUSION: A multiple day regimen of antibiotic prophylaxis was not more effective than a single day in preventing UTI for intravesical BTX injection. Use of any antibiotic prophylaxis was associated with a significantly lower incidence of UTI compared to no antibiotic.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Martin S, Zillioux J, Goldman HB, et al. Impact of Duration of Antibiotic Prophylaxis on Incidence of UTI after OnabotulinumtoxinA Injection. Urology. 2022. PMID: 35595075. doi:10.1016/j.urology.2022.05.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。